Neurocrine Biosciences In... (NBIX)
NASDAQ: NBIX
· Real-Time Price · USD
132.85
1.54 (1.17%)
At close: Aug 15, 2025, 3:59 PM
132.90
0.04%
After-hours: Aug 15, 2025, 04:34 PM EDT
Neurocrine Biosciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 107.5M | 7.9M | 103.1M | 129.8M | 65M | 43.4M | 147.7M | 83.1M | 95.5M | -76.6M | 89M | 68.5M | -16.9M | 13.9M | -7.3M | 22.5M | 42.3M | 32.1M |
Depreciation & Amortization | 7.3M | 7.6M | 7.1M | 6.5M | 7.3M | 6.2M | 5.7M | 5.5M | 5.1M | 5M | 4.4M | 4M | 3.9M | 3.3M | 3M | 2.8M | 2.6M | 2.5M |
Stock-Based Compensation | 52.8M | 52.8M | 66.4M | 41.5M | 43.1M | 44.5M | 38.1M | 47.8M | 68.5M | 39.9M | 43.5M | 43.1M | 49.5M | 37M | 35.6M | 37.1M | 28.6M | 32.9M |
Other Working Capital | n/a | n/a | 103.9M | -18.8M | -3.9M | -2.8M | 51.6M | -50.9M | 71.4M | -24.3M | -73.5M | -18.5M | 8.5M | -10.7M | 4.7M | -27.2M | 3.8M | 1.7M |
Other Non-Cash Items | -28.2M | 10.2M | 2.9M | 10.7M | 216.9M | 169.1M | -34.9M | 33.8M | -41.4M | -4.4M | -5.9M | -10.2M | 1.9M | -18.7M | -27.3M | 14.7M | 7.3M | 6.1M |
Deferred Income Tax | -37.4M | -13.7M | -31.3M | -34.9M | -41.3M | -15.6M | 20.6M | -4.2M | -41.5M | -31.6M | 13.5M | 9M | -3.1M | -300K | -4.7M | 5.7M | 9.5M | -6.2M |
Change in Working Capital | n/a | n/a | 94.3M | 4.4M | -86.3M | -31.6M | -53.7M | 46M | 93.4M | -57.5M | -1.5M | -15.6M | 25.4M | -75.7M | 4.9M | -21M | 12.9M | 19.9M |
Operating Cash Flow | 102M | 64.8M | 242.5M | 158M | 64.6M | 130.3M | 123.5M | 212M | 179.6M | -125.2M | 143M | 98.8M | 138.1M | -40.5M | 4.2M | 61.8M | 103.2M | 87.3M |
Capital Expenditures | -12.5M | -10.7M | -7.3M | -8.1M | -11.6M | -11.2M | -5.4M | -7.6M | -6.8M | -8.5M | -1.8M | 1.7M | -8.8M | -7.6M | -8.9M | -5.7M | -4.3M | -4.5M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | 5.4M | 89.7M | 6.8M | -2.2M | -42.7M | -1.7M | n/a | -12.2M | n/a | n/a | n/a | -700K |
Purchase of Investments | -315.1M | -273.2M | -311.8M | -232.5M | -191.7M | -320.1M | -487.2M | -362.7M | -323.8M | -237.5M | -233.3M | -134.2M | -60.9M | -200.5M | -141.4M | -280.2M | -289.4M | -93.7M |
Sales Maturities Of Investments | 298.6M | 298.1M | 250.8M | 265.3M | 175.1M | 276.3M | 290.8M | 273M | 204.7M | 203.9M | 162.2M | 71.2M | 101.1M | 176.5M | 174M | 159.7M | 202.9M | 161.3M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | -16.6M | -43.8M | -5.4M | -89.7M | -6.8M | 2.2M | -71.1M | 1.7M | 40.2M | 12.2M | n/a | n/a | n/a | 700K |
Investing Cash Flow | -29M | 14.2M | -68.3M | 24.7M | -28.2M | -55M | -201.8M | -97.3M | -125.9M | -42.1M | -115.6M | -61.3M | 31.4M | -31.6M | 23.7M | -126.2M | -90.8M | 63.1M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -279M | n/a | n/a | n/a | n/a | -100K |
Common Stock Repurchased | -17.7M | -150M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | -117.9M | -290M | 26.4M | -308.8M | 69.9M | 35.4M | 18.8M | 2.9M | 8.2M | 24.6M | 11.4M | 2.6M | n/a | 1.8M | 7.5M | 3M | 15.2M |
Financial Cash Flow | -3.3M | -117.9M | -290M | 26.4M | -293M | 69.9M | 35.4M | 18.8M | 2.9M | 8.2M | 24.6M | 11.4M | -276.4M | 6.1M | 1.8M | 7.5M | 3M | 15.1M |
Net Cash Flow | 69.9M | -38.9M | -116.1M | 209.4M | -256.6M | 145.2M | -42.6M | 133.5M | 56.6M | -159.1M | 50.7M | 48.9M | -106.9M | -66M | 29.7M | -56.9M | 15.4M | 165.5M |
Free Cash Flow | 89.5M | 54.1M | 235.2M | 149.9M | 53M | 119.1M | 118.1M | 204.4M | 172.8M | -133.7M | 141.2M | 100.5M | 129.3M | -48.1M | -4.7M | 56.1M | 98.9M | 82.8M |